US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

261.30

-4.7000-1.77%

Post-market: 261.760.4600+0.18%17:40 EDT

Volume:226.84K

Turnover:60.83M

Market Cap:489.80M

PE:- -

High:278.96

Open:273.29

Low:261.30

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:12.10%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Replimune to Present at the Cantor Global Healthcare Conference 2026

Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

DiagnosTear Seeks FDA Guidance for TeaRx Red Eye Diagnostic Test

Liquidia granted Fast Track designation to Yutrepia inhalation powder

Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)

American Healthcare REIT acquires eight senior housing communities for $696M

EPF Trims IHH Healthcare Stake but Retains Strong Institutional Holding

BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)

Phreesia: Buy Rating Reaffirmed on Upside Potential, $14 Price Target Maintained

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)

UBS Group AG exits substantial shareholder position in Sonic Healthcare

Health Care Roundup: Market Talk

Nokia, BeeHealthy Partner on Network-Based Verification for Digital Healthcare

MT Newswires Live

Penetrium Wins FDA Nod for Phase 2a Trial in Advanced Solid Tumors

Hybio Pharmaceutical's Pingshan Branch Passes US FDA Inspection

MT Newswires Live

Fisher & Paykel Healthcare Executive Options Lapse After Vesting Conditions Not Met

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":226839,"hourTrading":{"tag":"盘后","latestPrice":261.76,"preClose":261.3,"latestTime":"17:40 EDT","volume":132,"amount":34590.943199999994,"timestamp":1789162849766,"change":0.46,"changeRate":0.00176,"amplitude":0.008226},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Post-Mkt","change":-4.7,"latestTime":"09-11 17:42:51 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60826571.61735,"amplitude":0.066396,"askPrice":267.77,"askSize":400,"bidPrice":261.12,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003844,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.76,"preClose":261.3,"latestTime":"17:40 EDT","volume":132,"amount":34590.943199999994,"timestamp":1789162849766,"change":0.46,"changeRate":0.00176,"amplitude":0.008226},"volumeRatio":0.937556,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.937556,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"committee":-0.995012,"eps":0,"divideRate":0.003844,"volume":226839,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664877182","title":"Replimune to Present at the Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877182?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355852/0/en/replimune-to-present-at-the-cantor-global-healthcare-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","REPL","XLV","BK4588","LU0029874061.USD","BK4137","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877127","title":"Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877127?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355826/0/en/altimmune-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU0128525689.USD","LU0256863811.USD","LU1267930490.SGD","LU1506573853.SGD","BK4504","IE00B19Z3581.USD","LABU","LU0106831901.USD","LU0208291251.USD","LU2361044865.SGD","LU0130102774.USD","LU0154236417.USD","LU0320765489.SGD","LU0971096721.USD","LU0640476718.USD","BK4501","LU0310799852.SGD","LU0417517546.SGD","LU2236285917.USD","LU0162691827.USD","LU1035773651.USD","IYF","LU1280957306.USD","LU0072461881.USD","LU2361045086.USD","LU0029864427.USD","LU0251131958.USD","FTXO","LU0310800965.SGD","TFNS","BK4588","WFC","LU0267386448.USD","LU0310800379.SGD","BK4581","XBI","ALD","LU0708994859.HKD","LU0128526141.USD","LU1668664300.SGD","LU1201861249.SGD","LU0942090050.USD","HCSG","PGF","LU0648001328.SGD","XLV","LU0787776722.HKD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664771588","title":"Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664771588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664771588?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"Investors:. Dan Ferry. LifeSci Advisors. (617) 430-7576. Media:. Kathryn Morris. The Yates Network. (914) 204-6412","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355846/0/en/tectonic-therapeutic-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550494.USD","LU1074936037.SGD","BK4588","LU1989772923.USD","BK4504","LU2264538146.SGD","BK4137","BK4534","LU1988902786.USD","LU2487616109.SGD","LU0267386448.USD","LU0158827948.USD","LU1244550221.USD","BK4127","LABU","HCSG","LU1720051017.SGD","LU2271345857.HKD","IE00B775SV38.USD","LU0795875086.SGD","IE00BKVL7J92.USD","LU2028103732.USD","LU2111349929.HKD","LU1732800096.USD","LU0106831901.USD","BK4581","LU1668664300.SGD","LU1548497426.USD","MS","LU1162221912.USD","LU1791710582.SGD","LU0528227936.USD","IE00B3S45H60.SGD","BK4585","LU1064131342.USD","IAI","LU0128526141.USD","LU1363072403.SGD","LU2089284900.SGD","LU0210528500.USD","LU0314104364.USD","LU1720051108.HKD","LU0557290698.USD","XLV","XBI","KBWB","LU2357305700.SGD","TECX","BK4516","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664136877","title":"Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664136877","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664136877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355844/0/en/grace-therapeutics-to-participate-in-the-h-c-wainright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","LABU","BK4139","BK4007","BK4588","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871468","title":"Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871468?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:50","pubTimestamp":1788436225,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-lifecore-biomedical-lfcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-lifecore-biomedical-lfcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4137","LU0029874061.USD","XLV","BK4212","BK4139","XBI","BK4581","BK4585","LFCR","LABU","HCSG","RARE","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687905","title":"DiagnosTear Seeks FDA Guidance for TeaRx Red Eye Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687905","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687905?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:37","pubTimestamp":1788435462,"startTime":"0","endTime":"0","summary":"The latest update is out from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ). DiagnosTear Technologies has filed a pre-submission request with the U...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/diagnostear-seeks-fda-guidance-for-tearx-red-eye-diagnostic-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/diagnostear-seeks-fda-guidance-for-tearx-red-eye-diagnostic-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887183","title":"Liquidia granted Fast Track designation to Yutrepia inhalation powder","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887183?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:35","pubTimestamp":1788435315,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) announced that the FDA has granted Fast Track designation to Yutrepia inhalation powder for the treatment of Raynaud’s phenomenon a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-granted-fast-track-designation-to-yutrepia-inhalation-powder-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-granted-fast-track-designation-to-yutrepia-inhalation-powder-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4007","BK4585","BK4588","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664790228","title":"Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664790228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664790228?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:30","pubTimestamp":1788435019,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH) and Entrada Therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definitive-healthcare-corp-dh-and-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definitive-healthcare-corp-dh-and-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4167","BK4585","BK4588","DH","BK4581","XLV","BK4139","TRDA","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687659","title":"American Healthcare REIT acquires eight senior housing communities for $696M","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687659?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:35","pubTimestamp":1788431708,"startTime":"0","endTime":"0","summary":"American Healthcare REIT (AHR) announced the acquisition of eight Class A senior housing communities for approximately $696M, establishing a new op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/american-healthcare-reit-acquires-eight-senior-housing-communities-for-696m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/american-healthcare-reit-acquires-eight-senior-housing-communities-for-696m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQRA","AHR","BK4225","RNTY","MDIV","XLV","REIT","PSCF","BK4581","YLDW","BK4585","BK4588","BPRE","DFRA","XBI","HLGE","RJMG","REZ","LABU","IVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875422","title":"EPF Trims IHH Healthcare Stake but Retains Strong Institutional Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875422?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:17","pubTimestamp":1788430678,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) just unveiled an announcement. Malaysia’s Employees Provident Fund Board has marginally reduced its direct stake in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-trims-ihh-healthcare-stake-but-retains-strong-institutional-holding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-trims-ihh-healthcare-stake-but-retains-strong-institutional-holding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","BK4585","XLV","XBI","BK4588","BK4581","BK4137","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487549","title":"BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487549?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430536,"startTime":"0","endTime":"0","summary":"BioLargo (BLGO) announced that its subsidiary Clyra Medical Technologies is expanding distribution of its FDA-cleared ViaClyr wound irrigation solu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biolargo-subsidiary-adds-third-distribution-channel-accelerate-viaclyr-rollout-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biolargo-subsidiary-adds-third-distribution-channel-accelerate-viaclyr-rollout-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BLGO","BK4588","BK4109","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664730678","title":"Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664730678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664730678?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:40","pubTimestamp":1788428406,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Envista Holdings (NVST) and Alumis Inc. (ALMS). En...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4137","XBI","LU0128526141.USD","BK4585","LU0648000940.SGD","BK4082","LU0130103400.USD","LU0029874061.USD","NVST","ALMS","LU1201861165.SGD","BK4581","LU0130518102.USD","LABU","LU0477156797.USD","HCSG","IE00B19Z6F94.USD","IE0034390439.USD","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878187","title":"Phreesia: Buy Rating Reaffirmed on Upside Potential, $14 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878187?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:05","pubTimestamp":1788426324,"startTime":"0","endTime":"0","summary":"Phreesia, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ryan MacDonald from Needham reiterated a Buy rating ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/phreesia-buy-rating-reaffirmed-on-upside-potential-14-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/phreesia-buy-rating-reaffirmed-on-upside-potential-14-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","XLV","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664201820","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664201820","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664201820?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:40","pubTimestamp":1788424812,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phreesia-phr-alpha-tau-drts-and-fortrea-holdings-inc-ftre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phreesia-phr-alpha-tau-drts-and-fortrea-holdings-inc-ftre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU0029874061.USD","LU0128526141.USD","BK4588","BK4137","DRTS","BK4581","BK4585","FTRE","PHR","BK4121","BK4167","BK4082","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664203008","title":"UBS Group AG exits substantial shareholder position in Sonic Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664203008","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664203008?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:38","pubTimestamp":1788424681,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Sonic Healthcare Limited ( ($AU:SHL) ). UBS Group AG and its related bodies corporate have ceased to be a subst...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ubs-group-ag-exits-substantial-shareholder-position-in-sonic-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ubs-group-ag-exits-substantial-shareholder-position-in-sonic-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4534","IE0034235071.USD","BK4588","BK4118","BK4585","LABU","LU1863844749.USD","UBS","XBI","LU1829250122.USD","BK4581","LU3187612489.SGD","LU1863844665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827425","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827425?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:20","pubTimestamp":1788423600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0258 GMT - An increase in the Australian National Aged Care Clas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XBI","XLV","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827860","title":"Nokia, BeeHealthy Partner on Network-Based Verification for Digital Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827860","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827860?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:53","pubTimestamp":1788422033,"startTime":"0","endTime":"0","summary":"Nokia  has entered a commercial agreement with BeeHealthy to integrate its Network as Code platform into the digital healthcare provider's applications, the company said Thursday.The integration replaces SMS one-time passcodes, allowing patients to access healthcare services through automated number verification during log-in and booking, Nokia said.BeeHealthy will also embed Network as Code APIs to detect SIM swap fraud, location verification and KYC matching in its patient and professional applications, the company said.Financial terms were not disclosed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","HCSG","BK4137","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","LABU","LNOK","LU0128526141.USD","BK4585","LU0006061336.USD","BK4581","BK4588","XLV","BK4547","LU0029874061.USD","XBI","NOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664294888","title":"Penetrium Wins FDA Nod for Phase 2a Trial in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664294888","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664294888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 13:45","pubTimestamp":1788414350,"startTime":"0","endTime":"0","summary":"Penetrium Bioscience Inc. ( ($KR:187660) ) just unveiled an update. Penetrium Bioscience Inc. has received U.S. Food and Drug Administration cleara...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/penetrium-wins-fda-nod-for-phase-2a-trial-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/penetrium-wins-fda-nod-for-phase-2a-trial-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZL793.SGD","LU1815336091.USD","LU0274383776.USD","LU2931357623.SGD","BK4157","IE00B19Z4B17.USD","LABU","BK4585","BK4588","IE00B66KJ199.SGD","LU0757428866.USD","IE0031619046.USD","AEIS","LU2089985449.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664295898","title":"Hybio Pharmaceutical's Pingshan Branch Passes US FDA Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2664295898","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664295898?lang=en_us&edition=fundamental","pubTime":"2026-09-03 13:32","pubTimestamp":1788413524,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical's  Pingshan Branch in China passed the U.S. Food and Drug Administration's inspection after no deficiencies requiring regulatory action were found, according to a Shenzhen bourse filing on Thursday.The routine inspection was conducted between June 18 and June 26 in compliance with current good manufacturing practice  requirements for drug manufacturing.The Chinese pharmaceutical company's shares slipped 1% during the afternoon trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0070","BK4585","BK0077","BK0188","BK4588","BK0028","LABU","300199","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664259558","title":"Fisher & Paykel Healthcare Executive Options Lapse After Vesting Conditions Not Met","url":"https://stock-news.laohu8.com/highlight/detail?id=2664259558","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664259558?lang=en_us&edition=fundamental","pubTime":"2026-09-03 11:37","pubTimestamp":1788406646,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an announcement. Fisher & Paykel Healthcare has disclosed a change in th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-executive-options-lapse-after-vesting-conditions-not-met?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-executive-options-lapse-after-vesting-conditions-not-met?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK8004","FPH.NZ","BK4585","XLV","LABU","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":13,"totalSize":415,"code":"91000000","status":"200"}]}}